Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
22.39
P/B ratioShare price divided by book value per share.
3.92
P/S ratioMarket value divided by annual revenue.
4.23
PEG ratioP/E divided by the earnings growth rate.
0.37
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
25.03
EV / RevenueEnterprise value against annual revenue.
3.92
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
4.47%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
44.39%
Operating marginRevenue left after operating costs.
14.09%
Net marginRevenue left after every cost, including tax and interest.
19.38%
Return on equityProfit as a percentage of shareholders’ equity.
19.11%
Return on assetsProfit as a percentage of total assets.
5.07%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
1.90
Quick ratioThe same, excluding inventory.
1.57
Debt to equityTotal borrowings against shareholders’ equity.
0.01
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$0.18
Book value per shareShareholders’ equity divided by shares outstanding.
$1.03
Shares outstandingShares currently issued.
2,229,868,126
Market capitalisationShare price times shares outstanding.
$8.99B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
2,350
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.
What is HARBIN GLORIA PHARMACEUTICALS Co., LTD's P/E ratio?
HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) trades on a price-to-earnings ratio of 22.39.
What is HARBIN GLORIA PHARMACEUTICALS Co., LTD's return on equity?
HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) reports a return on equity of 19.11%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does HARBIN GLORIA PHARMACEUTICALS Co., LTD carry?
HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) has a debt-to-equity ratio of 0.01, which compares total borrowings with shareholders' equity.
What is HARBIN GLORIA PHARMACEUTICALS Co., LTD's profit margin?
HARBIN GLORIA PHARMACEUTICALS Co., LTD (002437.SZ) keeps 19.38% of revenue as net profit after every cost, including tax and interest.